Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SeaStar Medical
AddedFeb 15, 2024
UpdatedJul 5, 2026
SeaStar Medical

SeaStar Medical

Series C

CytoPherx Inc. offers proprietary medical devices for treating inflammation-based diseases.

HQ
Ann Arbor, MI, US
Founded
2007
Overview
Compare
Fundraising
Employees

CytoPherx Inc. is a medical device company focused on developing and providing proprietary systems for the treatment of inflammation-based diseases and conditions. Their core mission is to improve patient outcomes through innovative medical technologies that address inflammatory responses in various medical scenarios.

CytoPherx has made significant strides in the medical field with its advanced cytopheresis system, which has shown promise in treating a range of inflammation-related conditions. The company's impact is evident in its contributions to improving patient care and advancing medical technology.

SeaStar Medical - Similar Companies

Cytophil logo

Cytophil

cytophil.com

CytoSorbents logo

CytoSorbents

cytosorbents.com

Biophyx logo

Biophyx

biophyx.co

Piraeus Medical logo

Piraeus Medical

Infused Medical Technology logo

Infused Medical Technology

Phraxis logo

Phraxis

phraxis.com

SeptRx logo

SeptRx

ExThera Medical logo

ExThera Medical

extheramedical.com

Ionix Medical logo

Ionix Medical

Jan Medical logo

Jan Medical

janmedical.com

CytoAgents logo

CytoAgents

cytoagents.com

Concept Medical logo

Concept Medical

conceptmedical.com

Velomedix logo

Velomedix

Nectero Medical logo

Nectero Medical

necteromed.com

Procyrion logo

Procyrion

SeaStar Medical - Quick Facts

Who are SeaStar Medical's competitors?

Companies similar to SeaStar Medical include Cytophil, CytoSorbents, Biophyx and Piraeus Medical.

When was SeaStar Medical founded?

SeaStar Medical was founded in 2007.

Where is SeaStar Medical's headquarters located?

SeaStar Medical's headquarters is located in Ann Arbor, MI, US.

When was SeaStar Medical's last funding round?

SeaStar Medical's most recent funding round was for $34M (USD) in January 2012.

How much has SeaStar Medical raised to-date?

As of Jan 4, 2012, SeaStar Medical has raised a total of $50.2M (USD).

How many employees does SeaStar Medical have?

SeaStar Medical has 5 employees as of Feb 4, 2024.

SeaStar Medical - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
Unique IDs
  • secCik: 0001831868
  • ticker: ICU
  • ticker: ICUCW
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified